logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
Showing 1 - 7 of 7 Items
Showing 1 - 7 of 7 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Prescribing practices in the treatment of wasting: secondary analysis from a randomised trial

Rattigan SM, Grantz KH, Hanson K, Langendorf C, Berthé F,  et al.
2024-02-26 • BMJ Nutrition, Prevention & Health
2024-02-26 • BMJ Nutrition, Prevention & Health
INTRODUCTION
Current guidelines for the outpatient treatment of severe acute malnutrition (SAM) recommend the provision of routine medications to all children at admission and prescr...
Journal Article
|
Research

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

Juan-Giner A, Namulwana ML, Kimathi D, Grantz KH, Fall G,  et al.
2023-04-28 • Lancet Infectious Diseases
2023-04-28 • Lancet Infectious Diseases
BACKGROUND
Current supply shortages constrain yellow fever vaccination activities, particularly outbreak response. Although fractional doses of all WHO-prequalified yellow fever vacc...
Journal Article
|
Research

Burden and risk factors for relapse following successful treatment of uncomplicated severe acute malnutrition in young children: Secondary analysis from a randomised trial in Niger

Bliznashka L, Grantz KH, Botton J, Berthé F, Garba S,  et al.
2022-07-21 • Maternal and Child Nutrition
2022-07-21 • Maternal and Child Nutrition
This study aimed to quantify the burden of relapse following successful treatment for uncomplicated severe acute malnutrition (SAM) and to identify associated risk factors in rural Niger...
Journal Article
|
Research

Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial

Juan-Giner A, Kimathi D, Grantz KH, Hamaluba M, Kazooba P,  et al.
2021-01-09 • Lancet
2021-01-09 • Lancet
BACKGROUND
Stocks of yellow fever vaccine are insufficient to cover exceptional demands for outbreak response. Fractional dosing has shown efficacy, but evidence is limited to the 17...
Journal Article
|
Research

Factors influencing participation in an Ebola vaccine trial among frontline workers in Guinea

Grantz KH, Claudot P, Kambala M, Kouyate M, Soumah A,  et al.
2019-11-15 • Vaccine
2019-11-15 • Vaccine
BACKGROUND
Alongside the clinical aspects of the immunogenicity and safety trial of an Ebola vaccine deployed among front-line workers, a qualitative study was conducted to describe ...
Journal Article
|
Research

Factors influencing participation in an Ebola vaccine trial among front-line workers in Guinea

Grantz KH, Claudot P, Kambala M, Kouyate M, Soumah A,  et al.
2019-11-15 • Vaccine
2019-11-15 • Vaccine
BACKGROUND
Alongside the clinical aspects of the immunogenicity and safety trial of an Ebola vaccine deployed among front-line workers, a qualitative study was conducted to describe ...
Journal Article
|
Research

Extended follow-up from a randomized clinical trial of routine amoxicillin in the treatment of uncomplicated severe acute malnutrition in Niger

Isanaka S, Grantz KH, Berthé F, Schaefer MM, Adehossi E,  et al.
2020-03-01 • Journal of the American Medical Association (JAMA)
2020-03-01 • Journal of the American Medical Association (JAMA)
This study is an extended follow-up of a randomized clinical trial of routine amoxicillin use for infants experiencing uncomplicated severe acute malnutrition in Niger.